About Coherus Oncology
We are a commercial-stage oncology company, founded in 2010. We develop combination therapies to treat cancer, especially focusing on immune resistance. Our main drug is LOQTORZI® (toripalimab-tpzi), an FDA-approved anti-PD-1 monoclonal antibody. It’s used for recurrent or metastatic nasopharyngeal carcinoma (NPC), either with chemotherapy or on its own.
We also have two mid-stage clinical candidates in our pipeline, targeting liver, lung, head & neck, and other cancers. We’re working to expand LOQTORZI’s use in NPC and develop new uses in combination with our own pipeline drugs and those from partners. We have several clinical trials underway for our immuno-oncology treatments.
Our headquarters are in Redwood City, CA, with a lab in Camarillo, CA.
Mission & Values
Our mission is to develop and commercialize a range of immuno-oncology therapies. We aim to extend patient survival and improve treatment for serious illnesses.
We are passionate about bringing innovative immuno-oncology treatments to patients. Our team is dedicated to improving patient care and leading the way in new therapies.
Team & Culture
We have between 201 and 500 employees. Our culture is dynamic and rewarding, and we see our employees as our most valuable asset. We look for self-starters with an entrepreneurial spirit who want to make a real difference in patients’ lives.
Our team works alongside experienced biopharma professionals who are committed to improving patient care. We have experts in immunology, analytical and process sciences, biologic process development, manufacturing, supply chain management, clinical development, regulatory affairs, and commercial and marketing.
We encourage agility and transparency, and we value employee input. We are an equal opportunity employer and are committed to a workplace free of harassment and discrimination.
Benefits & Perks
We offer a competitive compensation package that includes a base salary and a performance-based bonus. Employees also receive stock options, healthcare coverage, and other benefits.
We cover 90% of premiums for employee medical, dental, and vision coverage, and 85% for spouses, dependents, and domestic partners. Other benefits include Paid Time Off (PTO), life insurance, a 401(k) plan, and a flexible spending account.
We support work-life balance through various activities, perks, and holidays.
Frequently Asked Questions
Coherus Oncology develops LOQTORZI® (toripalimab-tpzi), an anti-PD-1 monoclonal antibody approved for recurrent or metastatic nasopharyngeal carcinoma. The company also has a pipeline of two mid-stage clinical candidates targeting various cancers, focusing on next-generation immuno-oncology combination therapies.
Coherus Oncology offers a competitive base salary, performance-based target bonus, stock options, and comprehensive healthcare coverage with the company paying 90% of premiums for employees and 85% for dependents. Additional benefits include Paid Time Off (PTO), life insurance, a 401(k) plan, and a flexible spending account. The company also promotes work-life balance through various activities and perks.
Coherus Oncology cultivates a dynamic, rewarding, and transparent work environment that values an entrepreneurial spirit and encourages agility. Employees are seen as the most important asset and are encouraged to contribute their ideas. The company fosters a collaborative atmosphere, supported by activities and perks that promote a healthy work-life balance.
The Coherus Oncology team consists of experts in immunology, analytical and process sciences, biologic process development, manufacturing and supply chain management, clinical development, regulatory affairs, and commercial and marketing. The team has previous experience in successfully developing and commercializing biosimilars.
Coherus Oncology was founded in 2010.
Coherus Oncology is active in the Biotechnology, and Immuno-oncology markets.
Coherus Oncology has 201-500 employees.
Coherus Oncology hires in 🇺🇸 United States.
Yes! Coherus Oncology is actively hiring with 1 open remote job available now.
Yes, Coherus Oncology is a remote-first company.
Coherus Oncology's website is www.coherus.com .
You can find Coherus Oncology on X (Twitter) and LinkedIn .
1 remote jobs at Coherus Oncology
Explore latest remote opportunities and join a team that values work flexibility.
Remote companies like Coherus Oncology
Find your next opportunity with companies that specialize in Biotechnology and Immuno-oncology. Explore remote-first companies like Coherus Oncology that prioritize flexible work and home-office freedom.

Syndax Pharmaceuticals
Advancing cancer therapies from clinical trials to commercial-stage biopharmaceuticals.

Arcellx
A clinical-stage biotechnology company developing cell therapies for cancer and autoimmune diseases.

Recursion
A clinical stage TechBio company using AI and machine learning for drug discovery and development.

Cullinan Therapeutics
A clinical-stage biopharmaceutical company accelerating therapies for autoimmune diseases and cancer.

Day One Biopharmaceuticals
Develops targeted cancer treatments for children and adults.
Project: Career Search
Rev. 2026.2
[ Remote Jobs ]
Direct Access
We source jobs directly from 21,000+ company career pages. No intermediaries.
Discover Hidden Jobs
Unique jobs you won't find on other job boards.
Advanced Filters
Filter by category, benefits, seniority, and more.
Priority Job Alerts
Get timely alerts for new job openings every day.
Manage Your Job Hunt
Save jobs you like and keep a simple list of your applications.

